To Authorize Ivermectin For Human Use To Be Sold Without A Prescription Or Consultation With A Healthcare Professional.
Summary
SB189 amends Arkansas law to expressly allow ivermectin suitable for human use to be sold and purchased in the state as an over-the-counter medication. The bill defines over-the-counter medication as medication that may be legally sold and purchased without a prescription, and it states that ivermectin may be sold or purchased without a prescription or consultation with a healthcare professional, notwithstanding any contrary law.
In practical terms, the bill removes any state-law barrier that would require a prescription or pharmacist/clinician consultation for human-use ivermectin. It does not create a new licensing scheme or regulatory program; rather, it creates a specific statutory authorization in Title 20 of the Arkansas Code for ivermectin sales to occur without a prescription. The measure is aimed at retail access and affects consumers, pharmacies, and other sellers of medication in Arkansas.
Impact
The bill adds Arkansas Code § 20-7-147 to Title 20, Chapter 7, Subchapter 1, creating a direct exception to any state law that would otherwise require a prescription or healthcare consultation for ivermectin intended for human use. This changes the legal status of ivermectin in Arkansas by allowing it to be treated as an over-the-counter medication for human use, which could affect pharmacies, retailers, prescribers, and consumers by expanding access and reducing the role of healthcare professionals in dispensing decisions.
Sentiment
The available voting history suggests the bill had generally favorable support, with multiple third-reading votes passing by comfortable margins in both chambers. The bill’s approval indicates that a majority of lawmakers were willing to expand access to ivermectin without prescription requirements. No committee transcripts were provided, so there is no recorded committee debate to indicate broader public or legislative concerns beyond the floor votes.
Contention
The main point of contention is the removal of the prescription and consultation requirement for a medication used in human treatment, which raises questions about medical oversight, patient safety, and appropriate use. Supporters appear to favor consumer access and deregulation, while opponents likely object to bypassing healthcare professionals and to the possibility of misuse or self-medication. The bill text itself does not address safeguards, dosage controls, or pharmacist counseling requirements, which may be the central concerns for critics.